Detailed assessment of how the structural properties of T cell receptors affect clonal repertoires of Ag-specific cells is a prerequisite for a better understanding of human antiviral immunity. Herein we examine the ␣ TCR repertoires of CD8 T cells reactive against the influenza A viral epitope M1 58 -66 , restricted by HLA-A2.1. Using molecular cloning, we systematically studied the impact of ␣-chain usage in the formation of T cell memory and revealed that M1 58 -66 -specific, clonally diverse VB19 T cells express ␣-chains encoded by multiple AV genes with different CDR3 sizes. A unique feature of these ␣ TCRs was the presence of CDR3 fitting to an AGA(G n )GG-like amino acid motif. This pattern was consistent over time and among different individuals. Further molecular assessment of human CD4 ؉ CD8 ؊ and CD4 ؊ CD8 ؉ thymocytes led to the conclusion that the poly-Gly/Ala runs in CDR3␣ were a property of immune, but not naive, repertoires and could be attributed to influenza exposure. Repertoires of T cell memory are discussed in the context of clonal diversity, where poly-Gly/Ala runs in the CDR3 of ␣-and ␤-chains might provide high levels of TCR flexibility during Ag recognition while gene-encoded CDR1 and CDR2 contribute to the fine specificity of the TCR-peptide MHC interaction. and initiate formation of the supramolecular activation clusters between T cells and APCs (1-4). The T cells that have an identical clonal origin express a unique ␣␤ TCR that defines clonal fine specificity to Ag. Multiple clones with diverse, and to some extent overlapping, specificities provide protective immunity against viral infections. After viral clearance, a number of epitopespecific clones are retained, thus creating long-lasting memory TCR repertoires. It is currently agreed that clonal survival during and after viral clearance is a final result of multiple factors. Among these factors is the molecular nature of ␣␤ TCRs.
C D8 T cells express ␣␤ TCRs that bind to immunogenic peptides loaded into class I MHC molecules (pMHC)
and initiate formation of the supramolecular activation clusters between T cells and APCs (1) (2) (3) (4) . The T cells that have an identical clonal origin express a unique ␣␤ TCR that defines clonal fine specificity to Ag. Multiple clones with diverse, and to some extent overlapping, specificities provide protective immunity against viral infections. After viral clearance, a number of epitopespecific clones are retained, thus creating long-lasting memory TCR repertoires. It is currently agreed that clonal survival during and after viral clearance is a final result of multiple factors. Among these factors is the molecular nature of ␣␤ TCRs.
Ag-driven clonally expressed ␤ TCR repertoires have been intensively examined in experimental animal models (5-7) and human diseases (8 -11) . These studies have concluded that repetitive antigenic challenges correlate with increased frequencies of Agspecific, clonally diverse cells that share amino acid sequences within CDR3 of their expressed ␤ TCRs "fitting best" to epitope recognition. Since these memory cells are at high precursor frequencies and usually have lower TCR-mediated activation requirements than do naive cells, they provide rapid pathogen clearance in the case of reinfection. Although ␤ TCR-mediated selections in response to the immunogenic epitopes are well documented, little is known about ␣ TCR involvement in selection of human CD8 T cells.
Crystallization of TCR-pMHC has revealed that ␣-chains might provide a significant contribution to the interactive interface, varying from 37% to 74% of the total surface (12) (13) (14) (15) (16) . This implies that ␣ TCR usage might be a critical element that defines whether Ag-reactive cells are saved in a memory compartment. In this study, we sought to investigate ␣ TCRs expressed by memory cells, and we observed several previously unknown properties that might determine the clonal nature of memory repertoires.
Human CD8 T cell reactivity against the influenza A matrix (M1) protein-derived epitope, M1 58 -66 , represents an exceptional system to understand the molecular properties of ␣ TCRs expressed by memory cells selected in humans. Because the M1 protein is highly conserved among influenza A viral strains, reinfections during a lifetime (17) result in formation of the strong CTL recall responses against the M1 58 -66 epitope practically in all HLA-A2 (HLA-A*0201) individuals (10, 11, 18 -20) . For instance, by age 15 years HLA-A2 children possess a well-established M1-specific memory pool comprised of CD8 T cells expressing BV19 gene-encoded ␤-chains (formerly BV17) (20, 21) .
Our previous studies revealed that multiple VB19 clones specific to M1 58 -66 coexist in middle-aged individuals (22) (23) (24) . Those clones were defined based on the uniqueness of the nucleotide composition in the V-NDN-J regions encoding ␤-chains. Therefore, they were referred to as VB19 clonotypes since the ␣ TCR usage remained unknown. These influenza-specific clonotypes utilize BV19 gene-encoded ␤-chains with two CDR3 sizes fitting into IRSS-and IGS-like motifs. Although individual VB19 CD8 T clonotypes expressed structurally identical ␤ TCRs, they have different M1 58 -66 :HLA-A2.1 tetramer (M1 tetramer) binding capacity and peptide concentration-dependent proliferation in cell cultures (23) . This suggests that even if VB19 cells were selected due to the best CDR3␤ "fit" to M1 58 -66 :HLA-A2 recognition, their ␣ TCR usage could be different. Therefore, we reasoned that memory cells from a single family, VB19, could be used to examine the breadth of the memory ␣ TCR repertoire and provide insight on why ␤-VB19 chains alone are not exclusive determinants in clonal selection (10, 23) .
It has been reported that the optimal ␣␤ TCR interaction with pMHC requires that CDR3␣ and CDR3␤ should have similar sizes for proper engagement of V␣ and V␤ domains (25) . Our present study demonstrates that VB19 cells express AJ42 gene-encoded ␣ TCRs, which contain multiple (up to five) poly-Gly/Ala runs in the long CDR3␣, allowing engagement of cells from different VA families, thus utilizing different CDR1␣ and CDR2␣ in epitope recognition. This observation occurred in five individuals whose M1-specific cells were selected using M1 tetramer and VB19 mAbs. During the study period, we did not find preselection for poly-Gly/Ala runs in the CDR3␣ in human CD4
Ϫ CD8 ϩ thymocytes from the T cell subset (VA27-JA42) that was most prominent in response to flu-M1 58 -66 epitope. Taken together, our study led to the conclusion that the selection of T cells possessing poly-Gly/ Ala runs within their CDR3 was driven in response to the influenza A M1 58 -66 epitope rather than by biased gene recombination or thymic selection. We propose that the presence of poly-Gly/Ala runs in the CDR3s of ␣ and ␤ TCRs contributes to conformational flexibility of Ag-specific receptors. This implies that a robust immune response associates not only with T cells whose CDR3␣ and CDR3␤, which are generated during random gene recommendations, have the "fittest" complementarity to pMHC, but also with T cells whose Ag receptors utilize germline gene-encoded regions if CDR3s have high levels of flexibility.
Materials and Methods

Donors
Five healthy blood donors, donors A, B, C, D, and E (50, 47, 40, 56, and 26 years old, respectively), were defined to be HLA-A2.1 (HLA-A*0201)-positive based on MHC class I typing with the Biotest SSP (sequence-specific primer) system (Biotest Diagnostics).
Human thymus
Thymic tissue was collected as a discard during reconstructive surgical procedure on an HLA-A2.1-positive 3-mo-old child having a congenital cardiac defect, under a protocol approved by the Internal Review Board of The Children's Hospital of Wisconsin.
Influenza A peptide M1 58 -66 -specific CD8 T cell cultures
CD8 T cells were isolated from peripheral blood collected from donors A-E using anti-CD8 microbeads (Miltenyi Biotec), following the manufacturer's recommendations. The purity of isolated CD8 T cells usually was Ͼ95%. To generate peptide-specific cell lines, CD8 T cells (0.25 ϫ 10 6 cells/ml) were cocultured with TAP1/TAP2-defective target T2 (174 ϫ CEM.T2, American Type Culture Collection (ATCC)) cells (0.05 ϫ 10 6 cells/ml) in 4 ml complete culture medium/well. The T2 cells were incubated overnight with M1 58 -66 peptide (1 ϫ 10 Ϫ6 M). Before the setting of M1-specific cultures, peptide-pulsed T2 cells were irradiated (3000 rad) and intensively washed to avoid residual peptide. The complete culture AIM-V medium (Invitrogen) contained human rIL-2 (10 U/ml) (BD Pharmingen) and was supplemented with 14% supernatant from the IL-2-producing MLA 144 cell line (TIB 201, ATCC). The CD8 T cell lines were cultured in 12-well plates and split with rIL-2-containing media every 3 days. Once a week cultures were restimulated with peptide-coated, irradiated T2 cells. The cultures where T2 cells were not coated with peptide served as controls.
M1 58 -66 peptide synthesis
The peptide M1 58 -66 (GILGFVFTL) was synthesized on Pepsyn KA resin (BioSource International) using a 9050 PepSynthesizer (Millipore). Peptide was purified by reverse-phase HPLC (Ͼ90% purity) using a C18 column (Vydac).
VB19 mAb and M1 58 -66 /HLA-A2 tetramer staining
To examine the frequency of M1 58 -66 -specific VB19 cells, CD8 T cells were sampled from the cultured lines and costained with M1 58 -66 /HLA-A2.1 tetramer (M1 tetramer) (Beckman Coulter) and VB19 family-specific mAbs (Immunotech) according to the manufacturers' recommendations. Initially cells were stained with allophycocyanin-labeled M1 tetramer for 20 min at room temperature, and then FITC-labeled VB19 mAbs were added for an additional 20 min under the same conditions. The stained cells were washed in a copious volume of FACS buffer (PBS, 2% FCS, 0.2% sodium azide). Flow cytometry was performed using a FACSVantage and FACSCalibur (BD Biosciences). To isolate M1-specific cells, CD8 T cell line samples were stained with M1 tetramer and VB19 mAbs (donors A, B, and C) or M1 tetramer alone (donor D), and then FACS sorted using a MoFlo sorter (Dako). Purity of the FACS-sorted cells was Ͼ95% (data not shown).
Thymocyte staining and sorting
The thymus was disaggregated by passing through a wire mesh. Cells were suspended in RPMI 1640 medium (Invitrogen), 0.1% sodium azide, and 2% FCS, and stained with mouse mAbs to human cell surface markers: CD3-FITC conjugate, CD4-Tri-Color conjugate, and CD8-R-PE conjugate (Caltag Laboratories). A three-color sort was performed using FACStar (BD Biosciences), and single-positive CD4
ϩ CD8 Ϫ and CD4 Ϫ CD8 ϩ thymocytes were collected. Primary gating was set on the CD3 marker, which resolved the thymocytes into three populations, CD3 Ϫ , CD3 low , and CD3
high . The CD3 high population was further divided on the basis of CD4 and CD8 expression. Cells were collected into 0.5 ml of FCS so that the final concentration in the tube was 10% (5 ml final volume).
RNA isolation, cDNA synthesis, and titration
CD8 T cells separated from peripheral blood, cultured lines, or FACS sorting after M1 tetramer/VB19 mAbs staining were used for RNA isolation and cDNA synthesis as previously described (22, 26) . Genomic DNA was prepared from FACS-sorted thymocytes treated with nucleic acid lysis buffer (10 mM Tris (pH 8.2), 0.4 M NaCl, 2 mM EDTA) in the presence of SDS and proteinase (26) . Then the cells were incubated overnight at 45°C to ensure complete lysis. After the incubation, proteins were precipitated by adding 5.3 M NaCl, and DNA was precipitated from the supernatant with ethanol (27) . Before generation of ␣ TCR-specific CDR3 spectratypes, genomic DNA and cDNA samples were titrated using semiquantitative PCR amplification of the TCR CB region, as described (26, 28) . Briefly, serially diluted cDNA (or genomic DNA) aliquots were amplified 24 cycles using forward and reverse CB-specific primers under nonsaturating PCR conditions, and resolved on denaturing 50% urea/5% polyacrylamide gels. The cDNA (or genomic DNA) aliquots of cDNA that contained an equal quantity of total ␤ TCR transcripts were used for sequential CDR3␣ spectratype-generating PCR amplifications.
CDR3␣ spectratyping
Detailed descriptions of CDR3 spectratyping conditions were published previously (22, 26) . Briefly, cDNA samples were amplified in a PCR cocktail that contained forward VA family-specific primer and reverse CAspecific primer labeled from the 5Ј end with FAM. The nucleotide sequences of 34 VA family-specific and CA-specific primers were described elsewhere (29) . To examine the ␣ TCR repertoires of human thymocytes, genomic DNA samples were amplified using VA27-and JA42-specific primers. The PCR cycle consisted of 0.5 min at 94°C for denaturation, 0.5 min at 58°C for annealing, and 1.5 min at 72°C for elongation. The final elongation was extended to an additional 7 min at 72°C. After 31 cycles of PCR amplification, 10 l of VA-CA-amplified cDNA products were loaded and run on 50% urea/5% polyacrylamide sequencing gels for 2 h 15 min to 3 h 45 min depending on VA-CA primer combination. This technique ensures CDR3␣ bands visualization after gel scanning on the fluorescence detection system FluorImager 595 (Molecular Dynamics). Multiple CDR3␣ bands within a given VA family reflect clonal complexity based on ␣ TCR transcript size heterogeneity.
PCR product cloning and DNA sequencing cDNA samples generated from M1 tetramer/VB19 mAbs-stained, FACSsorted CD8 T cells (donors A-C), M1 tetramer-stained (donor D), and nonsorted cultured cells (donor E) were amplified with unlabeled CA-specific primer and one of VA family-specific primers in separate nonsaturated PCR reactions and immediately subcloned into the plasmid vector pCR4-TOPO (Invitrogen). The following cDNA libraries were generated and screened: VA8 (includes VA8.1 and VA8.3), VA8.6, VA10, VA12 (includes VA12.1, VA12.2, and VA12.3), VA27, VA29, VA34, and VA35. VB19-CDR3␤ plasmid subclones of donor A cultures were described elsewhere (23) . From 48 to 96 plasmid subclones from each VA cDNA library have been sequenced using a Taq DyeDeoxy terminator cycle sequencing kit (Applied Biosystems). Analysis of VA and JA regions flanking CDR3␣ nucleotide sequences indicated Ͻ0.25% divergence from the genomic sequences, which can be attributed to the MMLV reverse transcriptase and/or TaqDNA polymerase infidelity. The assignment to AV and AJ gene families of the subcloned and sequenced CDR3␣ plasmid inserts is given according to ImMunoGeneTics (IMGT). CDR3␣ size count includes C (from CASS) and F (FGXG) according to IMGT.
Supplemental material
The VA and JA family origins of the influenza A M1 58 -66 -specific VB19 clonotypes from donors A-E are shown in supplemental Table I . 4 Here we depict each clonotype number within VA cDNA libraries, their CDR3␣ sizes (aa), amino acid (highlighted in red), and nucleotide sequences within the AV-JA gene junction. The data sets corresponding to VA27-JA42 
Results
␣ TCRs expressed by M1 58 -66 -specific VB19 cells originate from multiple VA families
To define the breadth of the ␣ TCR repertoire of flu-specific cells that express VB19 ␤-chains with high affinity to the M1 58 -66 epitope (19), we used CDR3␣ spectratyping. Lack of available VA family-specific mAbs and the relatively low precursor frequency of M1 58 -66 -specific cells varying in a range of 0.1-0.8% in the peripheral blood CD8 T cells (30) were the two major reasons for using cell lines. To generate a sufficient number of cells to screen ␣ TCR families responding to the flu epitope, the CD8 T cells collected from five middle-aged HLA-A2 individuals were stimulated with irradiated T2 cells charged with the M1 58 -66 peptide to induce T cell division in vitro. After 3-5 wk in culture, cells were either FACS sorted after costaining with M1 tetramer and VB19 mAbs (donors A-C), M1 tetramer alone (donor D), or used directly (donor E). In our experiments, the purity of FACS-sorted cells gated as M1 tetramer ϩ or M1 tetramer ϩ VB19 ϩ populations usually exceeded 95% (data not shown).
We reasoned that by using RT-PCR amplification of cDNA samples with AV gene-specific primers, we would define ␣ TCR transcriptional profiles of the cells proliferating upon peptide stimulation and binding M1 tetramer. Therefore, cDNA samples generated from nonstimulated CD8 T cells and FACS sorted with M1 tetramer alone and with M1 tetramer/VB19 mAbs combined were amplified with VA-specific primers for 29 of 52 human ␣ TCR genes (29) . To examine the ␣ TCR repertoires of the peripheral 4 The online version of this article contains supplemental material. blood, CD8 T cells, and cells FACS sorted from the epitope-specific cultures, we ran off the RT-PCR products on the CDR3␣ spectratyping gels having assumed that the M1 58 -66 -specific cells would be selected within VA families. The increased fraction of M1 58 -66 -specific cells within each VA family was ascertained by increased densities of the selected CDR3␣ sizes detected on the gel images. To provide representative examples of the ␣ TCR repertoires of the unstimulated CD8 T cells and cells from the M1 58 -66 -specific cultures, we present CDR3␣ spectratypes from donor A ( Fig. 1) , whose ␣ TCR repertoire of peripheral blood CD8 T cells is shown in Fig. 1A . The ␣ TCR transcriptional profiles of donor A M1 tetramer ϩ (FACS sorted, week 4 culture) and M1 tetramer ϩ VB19 ϩ (FACS sorted, week 5 culture) cells across and within VA families are shown in Fig. 1 , B and C, respectively. The numbers on the x-axis indicate the VA family origin of ␣ TCR transcripts, while DNA bands resolved on the y-axis and their intensities represent proportions of ␣ TCR transcripts with identical CDR3 sizes within the respective families. Expecting that a repertoire of the peripheral blood CD8 T cells is extremely diverse, we observed multiple CDR3␣ bands within each of the VA families examined. While only 56% of the VA repertoire (29 of 52 families) was examined, we observed that CD8 T cells were derived from different VA families and utilized different CDR3␣ sizes. Representation of each VA family was skewed, with a high yield of VA24-, VA30-, and VA12-specific transcripts and a low yield of the VA14-, VA16-, and VA40-specific transcripts (Fig.  1A) . Interestingly, CDR3␣ spectratypes of the freshly isolated cells from donors B-E have similar patterns to donor A, namely: complexity of VA families, multiple CDR3␣ size usage within each of the VA families, and variation of these values among individuals (data not shown).
To gain insight about the M1 58 -66 -specific ␣ TCR repertoire, we ran off RT-PCR products from M1 tetramer ϩ CD8 T cells (FACS sorted, week 4 culture, donor A) as shown in Fig. 1B . The M1 tetramer ϩ cells expressed ␣ TCRs encoded by multiple VA families (VA8, 10, 14, 19 -24, 12, 27, 8.6, 22, 38.2, 41, and 29) . Remarkably, M1 58 -66 -specific cells from a few families utilized ␣ TCRs with different CDR3␣ sizes, as shown on VA12, VA27, VA8.6, and VA29 spectratypes (Fig. 1B, brackets) . To link the mentioned ␣-VA transcripts to VB19 ϩ cells, we sorted cells costained with M1 tetramer and VB19 mAbs. A representative example of ␣ TCR repertoire of the double-positive cells from donor A is shown in Fig. 1C . Again, we observed that M1 58 -66 -specific VB19 ϩ cells coexpressed ␣ TCRs encoded by different VA families with different CDR3␣ sizes (Fig. 1C) . Interestingly, CDR3␣ spectratypes of M1 tetramer ϩ cells ( Fig. 1B) were similar to those generated from the M1 tetramer ϩ VB19 ϩ subpopulation (Fig. 1C) . We showed that RT-PCR products from M1 tetramer ϩ and M1 tetramer ϩ VB19 ϩ cells were derived from VA8, VA10, VA12, VA27, VA8.6, VA22, and VA29 families. Although we did not align CDR3␣ bands within each VA spectratype, this observation reflects a complexity of the M1 58 -66 -specific recall ␣ TCR repertoire with engagement of different VA domains in pMHC recognition.
This observation is evidence that flu-specific VB19 ϩ cells utilized ␣ TCRs from different families, and the diverse CDR3␣ sizes further confirm our previous observations that VB19 ϩ cells have different clonal origins and avidities to the M1 58 -66 epitope (22) (23) (24) . Although we did not show ␣ TCR repertoires from donors B-E whose CD8 T cells were isolated from the peripheral blood and cell cultures, there were multiple ␣ TCR transcripts from FIGURE 2. Time-independent immunodominance of VA27 and VA8.6 cells in M1-specific CD8 T cell cultures (donor A). A, VA27 spectratypes. B, VA8.6 spectratypes. CD8 T cell cultures from donor A were generated every 12 mo and tested for M1 58 -66 -specific reactivity based on CDR3␣ spectratyping. The top numbers indicate the years when cultured lines were generated. The spectratypes are given for the CD8 T cell cultures (M1 culture) and cultures where cells were FACS sorted using M1 tetramer (M1-tet), VB19 mAbs, or both (M1-tet/VB19 mAbs). Sorted CD8 T cells isolated from the peripheral blood (ex vivo) and cultured without peptide (No peptide culture) were used as controls. The arrows indicate the subcloned and sequenced CDR3␣ bands. ϩ clonotypes within correspondent VA-cDNA libraries and their CDR3␣ nucleotide and deduced amino acid sequences are also available as supplemental Table I. M1 58 -66 -specific cells regardless of whether they were M1 tetramer/VB19-positive mAbs. Of note, since HLA-A2.1 T2 cells were used as APCs in our cell cultures, their ␣ TCR transcripts could be misinterpreted as specific to M1 58 -66 reactivity and affect the general picture of the recall ␣ TCR repertoires. Therefore, we screened ␣ TCR transcripts from T2 cells and defined that neither of the VA-specific primers used amplified ␣ TCRs. We concluded that ␣ TCRs from 4-to 5-wk cultures were derived from M1 58 -66 -specific CD8 T cells. Since allelic exclusion is not applicable to ␣ TCR gene rearrangement, the peripheral T cells express two ␣-chain mRNAs (derived from both chromosomes), and 25-30% of cells express two ␣ TCR proteins paired with a single ␤ TCR where only one ␣␤ TCR heterodimer binds self-MHC (31) (32) (33) . Considering the previous report where M1-specific VB19 clones were found to express primarily ␣-VA27 (formerly VA10.2) (11), it was somewhat surprising that VA27 ␣ TCR mRNA/cDNA transcripts did not dominate within the ␣ TCR transcriptional pools (Fig. 1, B and  C) . We reasoned that if the recall response was mediated by numerous VB19
ϩ clonotypes, then detection of multiple VA transcripts would be expected. However, if clonal cells were selected due to the molecular nature of their ␣ TCRs, then similarity in ␣ TCR repertoires would be revealed even if they were collected from different individuals. Thus, we tested ␣ TCR repertoires from four HLA-A2 blood donors. We thought that if only the VA27 family was involved in M1 58 -66 recognition, then the probability that flu-specific cells from different donors would have identical second ␣ TCRs (same VA families and CDR3␣ sizes) would be extremely low. However, if cells were selected based on ␣ TCR fitness to flu-M1 58 -66 :HLA-A2, then they would have similar CDR3␣ sizes and amino acid sequences of ␣ TCRs.
First, we reexamined whether flu-M1-reactive cells consistently utilized CDR3␣ of different sizes. Peptide-specific cultures from donor A were regenerated 12 mo apart and reexamined regarding ␣ TCR usage. The representative CDR3␣ spectratypes of VA27 and VA8.6 cells isolated from blood, mock, and M1 58 -66 -specific cultures are shown in Fig. 2 . We found that immunodominant CDR3␣ bands had identical sizes in all CD8 T cell lines and properly aligned with those from M1 tetramer ϩ sorted cells (Fig. 2,  arrows) . Based on spectratyping patterns, we concluded that VA27 ϩ cells evenly utilize three different CDR3␣ sizes, while VA8.6 cells express mostly long CDR3␣.
To further verify that flu-M1-reactive cells derived from different VA families express CDR3␣ of different sizes, we generated and screened VA spectratypes of the cultured cells from donors B-E. The representative VA27 and VA8.6 spectratypes of M1 tetramer ϩ VB19 ϩ (donor B), M1 tetramer ϩ (donor D), and nonsorted cultured (donor E) CD8 T cells, including controls, are shown in Fig. 3 . After M1 tetramer ϩ cells were sorted from cultures from donors B and C, we intentionally gated on M1 tetramer high VB19 high T cell populations. Again, we observed that flu-specific cells expressed AV27, 10, 8.6, 12 , and 29 gene-encoded ␣ TCR transcripts (not shown).
From these findings, we concluded that frequencies of VA27 and other families were low in peripheral blood and control cultures, since we used equalized quantities of RNA/cDNA transcripts from mock and peptide-specific lines. However, stimulation with influenza-derived M1 58 -66 peptide rapidly induced peptidedependent proliferation of T cells derived from diverse VA families. Although VA27 spectratypes with three CDR3␣ bands were remarkably similar between donors, we observed that patterns of VA8.6 and other VA usage varied between individuals. 
VB19
ϩ CD8 T cells express ␣-chains from 11 VA families with size-restricted CDR3␣. Amino acid residues in CDR3␣ loops are shown in red and blue. Nontemplate-encoded Ala and Gly are shown in blue and are interlined. CD8 T cells were isolated from M1 58 -66 -specific culture using M1 tetramer and VB19 mAbs (donor A).
Influenza M1 58 -66 -specific ␣ TCR repertoire: preferential selection for CDR3␣ size and poly-Gly/Ala runs
To better understand how influenza-specific cells might utilize ␣-chains encoded by different AV genes and having different CDR3␣ sizes, we used cDNA samples from M1 tetramer ϩ VB19 ϩ , M1 tetramer ϩ , and bulk M1 58 -66 -specific cultured CD8 T cells to generate VA family-specific cDNA libraries and sequenced CDR3 inserted into plasmid vector. Note that our methodology does not allow assigning TCR ␣-and ␤-chains to a single clone; however, we were confident that utilized cells were influenza M1 58 -66 -specific given that CDR3␤ spectratypings were overrepresented by VB19 family (Ref. 23 and data not shown). Hereafter, CDR3␣ sequences are referred to as "clonotypes" based on the uniqueness of nucleotide composition in the AV-N-AJ gene recombination sites. We thought that the number of CDR3␣ sequences within the VA cDNA library might serve as a proxy of the clonotypes' relative frequencies within the respective VA family, if the ␣ TCR repertoires possess a polyclonal nature. This also could validate M1 58 -66 -driven clonotype selection mediated through CDR3␣ amino acid compositions. The complete data sets of VA and JA usage, CDR3␣ sizes, and amino acid sequences of ␣ TCRs expressed by M1 58 -66 -reactive clonotypes from all five donors are available in supplemental Table I .
We have demonstrated that the ␣ TCR repertoire reactive against influenza was complex and included multiple VB19 ϩ clonotypes from multiple VA families with different CDR3␣ sizes. Hereafter, we examined repertoire structure where clonotypes from the JA42 family were considered as de facto M1 58 -66 -specific. Thus, we tabulated the number of clonotypes that share CDR3␣ sizes within VA families and determined proportions of the JA42 ϩ clonotypes across VA families and across CDR3␣ sizes. In Fig. 4 we illustrate the clonotype distribution by VA families and by CDR3␣ sizes (from 18 to 10 aa) for each donor (Fig. 4A) and overall (Fig. 4B) in a color-coded manner (Fig.  4C) . The color-coding system represents the number of clonotypes classified into five categories (shown in rows) and the proportions of corresponding JA42 ϩ clonotypes also classified into four categories (shown in columns in three degrees of shading). We also provide the summaries for the total number of all VA clonotypes, JA42
ϩ clonotypes, and their contribution (%) in all VA cDNA libraries by each CDR3␣ size and overall for each donor (Fig. 4A) and for all five donors (Fig. 4B ). For example, donor A had 105 clonotypes, out of which 67 (64%) clonotypes were JA42 ϩ ; the dominant CDR3␣ size was 15 aa, found in 40 clonotypes, of which 33 (83%) were JA42 ϩ (shown in bold).
We observed that the total number of detected clonotypes varied from 5 to 105, and JA42 ϩ clonotypes represented from 23% to 64% of all ␣ TCR repertoires. Among all donors, the distribution of clonotypes reflects that M1 58 -66 -specific T cells express CDR3␣ of different sizes; however, CDR3␣ with 12, 14, and 15 aa were dominant (Fig. 4A) . The dominance of specific VA families and specific CDR3␣ sizes was well pronounced in the overall summary (Fig. 4B) . We found that all VA8.1 ϩ clonotypes, 67% of VA27 ϩ clonotypes, and VA12.3 ϩ clonotypes expressed JA42-encoded ␣ TCRs. The JA42 usage associated with CDR3␣ sizes of 12 aa (80%), 15 aa (59%), and 14 and 16 aa (36% and 33%, respectively).
The high utilization of JA42 ϩ clonotypes with different CDR3␣ sizes from different VA families (on average 53%) upon epitope stimulation suggested that expression of VA27 ␣-chains by VB19 ϩ CD8 T cells is not an exclusive requirement to M1 58 -66 -specific reactivity. We also determined the following hierarchy of CDR3␣ sizes as a function of VA family origin, such as 15 Ͼ 12 Ͼ 14 aa residues. Moreover, if the VB19 ϩ clonotypes from the JA42 family are considered as M1 58 -66 -specific, then the hierarchy of VA usage can be presented as the following rule: VA27 (three CDR3␣ sizes and JA42) Ͼ VA8.6 and VA35 (two CDR3␣ sizes and JA42) Ͼ VA8.1 to VA29 (only CDR3␣ of 15 aa and JA42).
To investigate whether proper combination of CDR3␣ sizes and amino acid sequences is a strict requirement in M1 58 -66 recognition, while CDR1␣ and CDR2␣ usage is less stringent, we aligned ␣-chains of JA42 ϩ clonotypes originating from different VA families from all five donors (Tables I) involved in this study and from donor A (Table II) alone. Strikingly, many clonotypes contained poly-Gly/Ala runs where only two Gly were AJ42-gene encoded (Table II , underlined characters). Remarkably, the M1 58 -66 -specific clonotypes expressing long CDR3␣ chains (14 and 15 aa) contained nontemplate-encoded Gly/Ala runs (Table II , underlined characters) with other nonpolar, polar, and charged amino acids. Importantly, although ␣ TCRs might have identical amino acid sequences in CDR3, they were encoded by different nucleotide sequences generated during AV-N-AJ42 gene recombination that serves as clonotype marker (available as supplemental Table I ). Based on the collected and analyzed data sets, we defined the following rules in CDR3␣ usage: AGAGGGG in CDR3␣ with 15 aa; AGAGGG in CDR3␣ with 14 aa; and AGGG in CDR3␣ with 12-aa residues. Although we generated and screened the VA cDNA libraries of different sizes for each individual (Fig. 4A) , this pattern was consistent between the studied subjects (Table I) .
Thymic VA27-JA42 repertoire assessment: poly-Gly/Ala run in CDR3␣ is a property of M1 58 -66 :HLA-A2 epitope-selected memory cells
The presence of nontemplate poly-Gly/Ala runs in TCR ␣-chains expressed by flu-specific T cells could either reflect the CDR3␣ amino acid sequence distribution in naive T cells emerging from the thymus, or it could reflect a preferential selection of these sequences during flu-specific immune responses. To examine whether poly-Gly/Ala runs are a property of M1 58 -66 -specific memory, we examined AV27-N-AJ42 gene recombination in human CD4 ϩ CD8 Ϫ and CD4 Ϫ CD8 ϩ thymocytes. We reasoned that if poly-Gly/Ala is an intrinsic property of the long CDR3␣, then this motif could be defined in CD4 ϩ CD8 Ϫ (4SP) and CD4 Ϫ CD8 ϩ (8SP) thymocytes. Therefore, thymic tissue was used for 4SP and 8SP thymocyte isolation, genomic DNA preparation, and PCR amplification, using VA27 and JA42 family-specific primers. The flow cytometry data and corresponding VA27-JA42 spectratypes are shown in Fig. 5 . In addition to thymic spectratypes, we used spectratypes of the M1 58 -66 -specific culture and sorted M1 tetarmer ϩ VB19 ϩ T cells that served as the positive controls for CDR3␣ sizes.
As shown in Fig. 5B , the proportions of 4SP and 8SP thymocytes that have CDR3␣ composed of 12-aa residues were underrepresented within the VA27 ϩ JA42 ϩ population, yet they were abundant in bulk epitope-specific culture and within M1 tetramer ϩ VB19 ϩ populations. To further examine the presence of poly-Gly/Ala runs in conjunction with CDR3␣ sizes, we cloned and sequenced 400 and 300 CDR3␣ plasmid subclones from the 8SP and 4SP thymocytes, respectively. Here, we defined 129 "inframe" rearrangements for 8SP thymocytes and 89 "in-frame" rearrangements for 4SP thymocytes. This frequency was expected since two of three rearrangements generate nonproductive CDR3␣. As a control, we also used VA27-JA42 subclones from bulk M1 58 -66 -specific culture (donor A, year 2004, 5-wk culture) and M1 tetramer ϩ VB19 ϩ sorted populations (donor A, year 2002, 4-wk culture). The ␣ TCR repertoire profiles of the VA27-JA42 ϩ clonotypes from the 8SP and 4SP thymocytes and cultured CD8 T cells are available as supplemental Table II. Although 8SP thymocytes utilizing CDR3␣ of 14-and 15-aa residues were dominant based on spectratyping results (Fig. 5B) , more clonotype diversity was observed among cells using CDR3␣ of 12-aa residues (20%, 13 of 66 clonotypes) and 15-aa residues (31%, 21 of 66 clonotypes) (supplemental Table II, CD4 Ϫ CD8 ϩ thymocytes). The similar weak association between CDR3␣ band intensity on spectratyping and clonotype diversity was seen for 4SP thymocytes (supplemental Table II , CD4 ϩ 8 Ϫ thymocytes). Only one dominant clonotype detected among 8SP thymocytes represented 11% (14 of 129 sequences) of the population and used short CDR3␣ (11 aa) created by bland AV27 and AJ42 gene ligation.
Since we were interested to examine whether TCR interaction with HLA-A2 would preferentially select cells based on CDR3␣ sizes with nontemplate-encoded Gly/Ala runs, we examined the occurrence of poly-Gly/Ala runs by plotting frequencies of these amino acids, for all clonotypes, as a function of the CDR3␣ sizes (Fig. 6) . The Gly/Ala runs could be encoded if linking the AV27 gene (CAG) with the AJ42 gene segment (GGSQG. . . ) occurs after deletion of one nucleotide from the 3Ј end of the AV27 gene and seven nucleotides from the 5Ј end of AJ42 gene. Therefore, we expected to observe Gly and Ala strings in a short CDR3␣. However, we were interested whether the long (14 -15-aa) CDR3␣ were enriched by nontemplate Gly/Ala. As shown in Fig. 6A , the frequency of nontemplate Gly/Ala in 8SP thymocytes with 14 -15 aa in CDR3␣ was below detection level, considering the number of identified clonotypes, similar to what was observed for 4SP (0 -5%) clonotypes (Fig. 6B) . However, proportions of cells with nontemplate Gly and Ala were in the range of 40 -60% (12 of 17 clonotypes) for M1 tetramer ϩ VB19ϩ cells ( Fig. 6C ) and 40 -90% (10 of 26 clonotypes) for CD8 T cells that proliferated in the peptide-specific culture (Fig. 6D) . Therefore, we conclude that the increased frequency of Gly/Ala runs is associated with flu M1 58 -66 -driven selection rather than with V-J recombination and thymic selection.
Discussion
A detailed assessment of the TCR repertoires of Ag-specific T cells is a prerequisite for a better understanding of human antiviral immunity. Here we systematically examined the ␣ TCR repertoires of memory CD8 T cells reactive against the influenza A viral epitope, M1 58 -66 , restricted by HLA-A2.1. The M1 58 -66 -specific, clonally diverse VB19 CD8 T cells expressed ␣-chains from several VA families with different CDR3 sizes. A unique feature of these ␣ TCRs was the presence of poly-Gly/ Ala runs in the CDR3, fitting to an AGA(G n )GG-like amino acid motif. These nontemplate-encoded poly-Gly/Ala runs in the CDR3 of the M1 58 -66 -specific memory pool were significantly enriched over those in naive thymocytes, indicating that Gly/Ala runs provided a selective advantage in Ag-driven repertoire development in the periphery. These poly-Gly/Ala runs in the CDR3 of ␣-and ␤-chains might provide enhanced TCR flexibility during Ag recognition.
The mechanisms that shape T cell memory through ␣ TCR selection have been difficult to delineate due to the technical restraints associated with the lack of VA-family specific mAbs and T cell ability to coexpress two ␣-chains (31, 33, 34) . Nevertheless, our molecular cloning techniques demonstrate that the influenza A M1 58 -66 -specific T cell memory contains a number of additional features contributed by ␣ TCR diversity. These TCR ␣-chains that paired with the VB19 ␤-chains were of 11 VA families with three remarkably different sizes in CDR3␣ (Fig. 4B) . Given that the M1-specific clonotypes from different VA families express different CDR1␣ and CDR2␣ (Table II) , proper accommodation of different CDR1␣ and CDR2␣ to the M1 58 -66 -:HLA-A2 might occur if the CDR3␣ could undergo conformational adjustment. In this regard, enrichment of Gly and Ala might provide increased structural flexibility in CDR3␣ and satisfy this criterion.
It is commonly accepted that the fine specificity of epitope recognition is due to structural complementarity of CDR3␣ and CDR3␤ to MHC-presented immunogenic peptides under conditions where CDR1 and CDR2 orient the TCR ␣-and ␤-chains to MHC molecules. In contrast to Abs that usually have large surfaces with complementarity to their cognate Ags (35) , only 21-34% of the ␣␤ TCR's surfaces are in direct contact with pMHC complexes (16, 36) . Moreover, the contributions of CDR3␣ and CDR3␤ are relatively small, representing 21% and 24% on average of V␣ and V␤ domains, respectively. These properties of TCR-pMHC interactions impose strict requirements on ␣-and ␤-chains. For example, side chains of amino acids located within the CDR3 must have optimized sizes and charges to interact with the foreign peptide, and CDR3 of ␣-and ␤-chains ought to have the similar sizes (25) . However, we show examples where short CDR3␣ (12 aa) pair with one amino acid longer VB19-CDR3␤ (counting from C (CAS) to F (FGXG)), similar to crystallized ␣␤ TCR expressed by M1 58 -66 -specific clone JM22 (37) . The CD8 T cells from VA27 and VA8 families in five studied individuals mostly expressed these short CDR3a loops. In contrast, longer CDR3␣ sequences (14 and 15 aa) were found with VA families other than VA27 and VA8. These "non-VA27" VB19 ϩ T cells share ␣-JA42 chains with VA27 T cells (Fig. 4B) , but express different CDR1 and CDR2 of their ␣-chains (Table III) . Given that VB19 cells express rigid CDR3␤ fitting into the "IRSS-" or "IGS"-like motifs, a plausible explanation that structurally different V␣ domains are used to recognize influenza epitope is that the CDR3␣ loops undergo significant conformation (38) associated with poly-Gly/Ala runs. We therefore suggest that the CDR3␣ bearing long poly-Gly/Ala strings allow CDR1␣ and CDR2␣ encoded by different VA families to be used during influenza Ag recognition, and we discuss the theoretical basis for this suggestion below.
AJ42 gene-encoded products are not unique in the sense of containing two Gly runs, since 7 out of 51 AJ genes encode two, and even three, Gly. However, 59% (37 of 63) of the clonotypes with CDR3␣ with 15 aa belong to this particular JA42 family (Fig. 4B) . It seems that the combination of long CDR3␣ with poly-Gly/Ala runs provides flexibility for ␣␤ TCR to bind to the M1 58 -66 : HLA-A2 epitope, since we defined only eight clonotypes from "non-VA27" families (namely, VA10, 8.6, VA34 and VA35) that expressed short CDR3␣ of 12 aa (Fig. 4B) . Gly is a unique amino acid because it lacks a side chain, and Ala contains only a methyl group as a side chain. It has been shown that proteins whose functions depend on adjustment to ligands often contain flexible loops. Usually Gly is located within these loops, providing flexibility in protein-protein or protein-ligand interactions. For example, polyGly strings have been found in the HIV protease flap region, in ␤1,4-galactosyltransferase-I, fructose-1,6-bisphosphate aldolase, and other enzymes (39 -41) . TCR contact with the pMHC molecule also follows the same rule. Thermodynamic studies of three TCR-pMHC binding, including ␣␤ TCR from M1 58 -66 -specific clone JM22, revealed that this process correlates with considerable conformational adjustment in CDR3␣ and CDR3␤ (42, 43) . For instance, Reiser and coworkers reported that KB5-C20 (TCR specific to pKB1/H-2K b ) exhibits large conformational alteration in the CDR3␤ (six amino acids longer than CDR3␣) for proper accommodation to pMHC (15) . Recently, the same group reported that similar structural flexibility might be observed in CDR3␣ (BM3.3 specific to two peptides with low sequence similarity presented by H-2K b ) (13) . Based on these studies, the authors concluded that ␣␤ TCR propensity to modify its complementarity surface, mostly in the CDR3, might be the origin of ␣␤ TCR intrinsic ability to interact with the different epitopes. In line with these studies is the observation of structural flexibility of the ␣␤ TCRs expressed by human T cell clones reactive against Tax [11] [12] [13] [14] [15] [16] [17] [18] [19] peptide (from HTLV) presented by HLA-A2.1 (44, 45) . Remarkably, these clones expressed ␤ TCRs (VB13.1) that contained a PGxG motif in the CDR3␤ and efficiently recognized the original epitope and its variants. Another proof outlining the importance of TCR structural flexibility in epitope recognition comes from the crystallization of the ␣␤ TCRS expressed by clone LC13 specific to EBNA-3 339 -347 peptide presented by HLA-B8. In this case, AlaGlyGly runs were contained in the CDR3␤ (46) .
The occurrence of poly-Gly runs in ␤ TCRs with a long CDR3 is attributed to the D region where VDJ gene transcription in three "open-reading-frames" would encode multiple Gly. This rule, however, cannot be applied to ␣ TCRs lacking D-encoded regions. The existence of VB19 clones specific to flu-M1 58 -66 that utilize ␣ TCRs from different VA families provides an interesting example of epitope recognition where germline-encoded segments of ␣-chains (i.e., SQG from AJA42 gene) contact M1 58 -66 , while segments created by AV/AJ42 recombination are positioned outside M1 58 -66 :HLA-A2 and could be flexible due to Gly/Ala enrichment (37, 42) . A recent study of the ␣␤ TCR (from clone JM22 specific to M1 58 -66 -epitope) before and after binding to M1 58 -66 : HLA-A2 revealed that the CDR3␣ loop swiveled and made an ϳ5 Å outward shift (37, 42) . Note that the CDR3␣ loop from JM22 contains only 12 aa. Therefore, we are confident that the CDR3␣ with 14 and 15 aa defined in our study might have considerably more rotation and movement during M1 58 -66 :HLA-A2 binding and allow the CDR1␣ and CDR2␣ from different VA families to interact with HLA-A2 ␣1 helix.
A less explored field in human immunology is the analysis of the molecular nature of the preimmune ␣ TCR repertoire. In our study, we could not exclude the possibility that poly-Gly/Ala runs might be a result of preferential AV27/AJ42 recombination where long CDR3␣ might have increased frequencies of Gly and Ala. If this were the case, we would have expected to see increased observations of Gly and Ala in CD4 Ϫ CD8 ϩ and CD4 ϩ CD8 Ϫ thymocytes regardless of class I and II HLA restrictions. Importantly, we examined the transcriptional profiles of ␣ TCRs where VA27/JA42 transcripts might encode functional (restricted by HLA-A2.1) and nonfunctional TCR ␣-chains. Following extensive sequencing analysis of AV27/ AJ42 gene recombination and considering CDR3␣ sizes, we concluded that Gly and Ala have similar frequencies with other amino acids encoded by nontemplate segments of the VA27/ JA42 rearranged genes ( Fig. 6 and supplemental Table II) . Although two Gly are derived from the AJ42 gene, as was expected since we examined VA27/JA42 transcripts, the nontemplate segments of long CDR3␣ (i.e., 14 and 15 aa) were not Gly-and Ala-enriched. Therefore, we conclude that selection for poly-Gly/Ala runs was driven in response to M1 58 -66 epitope during influenza exposure rather than by a gene recombination.
The flexibility of the ␣␤ TCR structure might be an important factor in the fate of memory T cells. In the case of influenza M1 58 -66 -specific cells, the poly-Gly/Ala runs do not contact M1 58 -66 or HLA-A2 directly, based on the crystallization of the representative M1 58 -66 -specific JM22 clonal ␣␤ TCR and its variants (37, 42) . Although the recognition M1 58 -66 :HLA-A2 is a function of VB19 ␤-chain (ϳ70% of interactive interface), the ␣ TCRs with a highly flexible CDR3 might be used to recognize structurally different Ags, thus contributing to the pattern of T cell cross-reactivity, which we have observed in "heterologous immunity" (47) . If this is the case, influenza-specific VB19 T cells with IRSS in CDR3␤ might engage CDR1␣ and CDR2␣ during recognition of other p:HLA-A2, perhaps further enhancing the immunodominance of VB19 T cell clones.
Here we propose a three-step model explaining TCR interaction with the M1 58 -66 /HLA-A2.1 complex (Fig. 7) . In the first step, CDR1␤ and CDR2␤ (␤-VB19) contact the ␣2 helix of HLA-A2.1, pivoting the CDR3␤ to the peptide wherein R98 anchors the ␤-chains to HLA-A2 and S99 interacts with the M1 58 -66 peptide. In the second step, the SQG (AJ42 gene encoded) anchors the CDR3␣ loop to Gly61 (M1 58 -66 ), and the long CDR3␣ (poly-Gly/ Ala) undergoes conformational change. Since AGA(G/A)G in CDR3␣ imposes minimal energy requirement to change shape, this leads to the third step, where engagement of different CDR1,2␣ (from any of the VA domain) is sufficient for final TCR:M1 58 -66 / HLA-A2.1 docking. The key element of this model is a long polyGly/Ala moiety, which allows CDR3␣ to be extremely flexible and adjust different TCR V␣ domains to the same pMHC complex. If long CDR3␣ and/or CDR3␤ are more flexible and accommodate ␣␤ TCRs to different pMHC shapes and charges, then cross-reactivity against different Ags might be a major factor in memory formation. Of note, in our studies we also defined, based on tetramer binding, "non-VB19" cells that were able to recognize the M1 58 -66 /HLA-A2 epitope. Remarkably, they also expressed long (15-aa) CDR3␤ with a GXGG motif (Y. N. Naumov, unpublished).
The early studies of the cytotoxic CD8 T cell lines and clones reactive against M1 57-68 -expressing targets cells revealed that M1 57-68 peptide modifications in positions 58 -60 were well tolerated, while modifications in positions 61-65 could abrogate CTL response. In the last case, however, diminished cytotoxicity was not absolute and depended on amino acid substitutions. Interestingly, the T cell clones derived presumably from VB19 family have different patterns of epitope dependency in the CTL assay (10) . Our own study demonstrated that small populations of the VB19 T cells are able to proliferate and to produce IFN-␥ in response to influenza M1 58 -66 and EBV-BMLF1 280 -288 epitopes (30) . Although we did not yet define the structure of the crossreactive ␣␤ TCRs, these observations suggest that conformational flexibility of ␣␤ TCRs and clonal diversity of reactive T cells might be the best way to cope with different Ags.
In conclusion, we suggest that the immune response evolves in a way where it engages T cells with structurally different ␣␤ TCRs specific to cognate Ags leading to an intrinsic capacity of these T cells to interact with different pMHC shapes and charges. It is tempting to speculate that the presence of multiple memory CD8 T cell clones of diverse specificities due to adjustable Ag receptors is the best way to optimize immune memory to ever-changing antigenic environment. 
